Praxis Precision Medicines PRAX
NASDAQ PRAX
$300.65 +1.78 (+0.60%)
At close: Sep 22, 2026 · 4:00 PM EDT

Praxis Precision Medicines (PRAX) Cash from Investing Activities (2021 - 2026)

Praxis Precision Medicines (PRAX) posted Cash from Investing Activities of $11.0 million for Q2 2026, up 103.19% on a QoQ basis from -$344.3 million in Q1 2026, and down 38.63% year-over-year from $17.9 million in Q2 2025.

Analysis

Praxis Precision Medicines (PRAX) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Praxis Precision Medicines has reported Cash from Investing Activities for 6 years, with the latest figure at $11.0 million in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 38.63% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was -$611.3 million, a 11258.65% decrease from a year earlier, with the FY2025 full-year figure at -$311.1 million, down 25.21% from the prior year.
  • Cash from Investing Activities was $11.0 million for Q2 2026 at Praxis Precision Medicines, up from -$344.3 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $50.4 million in Q3 2025, with the low at -$344.3 million in Q1 2026.
  • Average Cash from Investing Activities over 5 years is -$44.5 million, with a median of $5.0 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities soared 497.66% in 2023, then sank 21736.0% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $22.6 million in 2022, then sank by 100.22% to -$50000.0 in 2023, then tumbled by 21736.0% to -$10.9 million in 2024, then plunged by 2907.79% to -$328.4 million in 2025, then surged by 103.34% to $11.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at $11.0 million (Q2 2026), -$344.3 million (Q1 2026), and -$328.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn -569.00 Mn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn -10.35 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn -45.80 Mn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn -92.70 Mn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 329.00 Mn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn -363.46 Mn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn -3.84 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn 281.26 Mn
10 Praxis Precision Medicines 8.34 Bn 7.58 Bn - 10.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.98 Mn
Mar 31, 2026 -344.28 Mn
Dec 31, 2025 -328.39 Mn
Sep 30, 2025 50.41 Mn
Jun 30, 2025 17.89 Mn
Mar 31, 2025 -51.06 Mn
Dec 31, 2024 -10.92 Mn
Sep 30, 2024 49.57 Mn
Jun 30, 2024 -195.92 Mn
Mar 31, 2024 -91.22 Mn
Dec 31, 2023 -50,000.00
Jun 30, 2023 5.00 Mn
Mar 31, 2023 34.00 Mn
Dec 31, 2022 22.59 Mn
Sep 30, 2022 47.96 Mn
Jun 30, 2022 34.89 Mn
Mar 31, 2022 -8.55 Mn
Dec 31, 2021 10.17 Mn
Sep 30, 2021 13.55 Mn
Jun 30, 2021 -24.23 Mn
API Access

Praxis Precision Medicines Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PRAX&period=max&api_key=YOUR_API_KEY